Jenny Zheng

Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

Ping Zhao, Manuela de Lima Toccafondo Vieira, Joseph A. Grillo et al. · The Journal of Clinical Pharmacology · 2012 · 96 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours

Leonid Gibiansky, Liviawati Sutjandra, Sameer Doshi et al. · Clinical Pharmacokinetics · 2012 · 92 citations

Medicine, Pharmacokinetics, Pharmacology +14

Time-and concentration-dependent penetration of doxorubicin in prostate tumors

Jenny Zheng, Chiung‐Tong Chen, Jessie L.‐S. Au et al. · AAPS PharmSci · 2001 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

Chandrasekar Durairaj, Ana Ruiz-Garcı́a, Eric Gauthier et al. · Anti-Cancer Drugs · 2018 · 44 citations · Full text

Medicine, Oncology, Pharmacology +15

Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib

Jenny Zheng, Yanke Yu, Chandrasekar Durairaj et al. · Targeted Oncology · 2020 · 33 citations · Full text

Pharmacy, Oncology, Pharmacology +17